| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.004 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |